Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Beginning Balance, Shares at Mar. 31, 2019	20,765,592
Beginning Balance, Amount at Mar. 31, 2019	$ 20,766	$ 15,971,905	$ (13,425,879)	$ (339,888)	$ 2,226,904
Issuance of common shares, net of offering costs, Shares	14,338
Issuance of common shares, net of offering costs, Amount	$ 14	142,903			142,917
Exercise of warrants, Shares	2,500
Exercise of warrants, Amount	$ 2	25,998			26,000
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	20,500
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 21	191,928			191,949
Foreign currency translation adjustment				(23,152)	(23,152)
Net loss			(2,368,305)		(2,368,305)
Ending Balance, Shares at Sep. 30, 2019	20,802,930
Ending Balance, Amount at Sep. 30, 2019	$ 20,803	16,332,734	(15,794,184)	(363,040)	196,313
Beginning Balance, Shares at Jun. 30, 2019	20,801,680
Beginning Balance, Amount at Jun. 30, 2019	$ 20,802	16,320,359	(14,677,144)	(355,639)	1,308,378
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	1,250
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 1	12,375			12,376
Foreign currency translation adjustment				(7,401)	(7,401)
Net loss			(1,117,040)		(1,117,040)
Ending Balance, Shares at Sep. 30, 2019	20,802,930
Ending Balance, Amount at Sep. 30, 2019	$ 20,803	16,332,734	(15,794,184)	(363,040)	196,313
Beginning Balance, Shares at Mar. 31, 2020	20,850,848
Beginning Balance, Amount at Mar. 31, 2020	$ 20,851	16,589,272	(17,586,075)	(336,992)	(1,312,944)
Issuance of common shares, net of offering costs, Shares	1,994,924
Issuance of common shares, net of offering costs, Amount	$ 1,995	14,791,484			14,793,479
Exercise of warrants, Shares	37,933
Exercise of warrants, Amount	$ 38	394,437			394,475
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	10,000
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 10	63,190			63,200
Foreign currency translation adjustment				(14,510)	(14,510)
Net loss			(2,681,273)		(2,681,273)
Ending Balance, Shares at Sep. 30, 2020	22,893,705
Ending Balance, Amount at Sep. 30, 2020	$ 22,894	31,838,383	(20,267,348)	(351,502)	11,242,427
Beginning Balance, Shares at Jun. 30, 2020	21,282,133
Beginning Balance, Amount at Jun. 30, 2020	$ 21,282	20,957,486	(18,686,131)	(332,169)	1,960,468
Issuance of common shares, net of offering costs, Shares	1,601,572
Issuance of common shares, net of offering costs, Amount	$ 1,602	10,817,707			10,819,309
Restricted shares issued as stock- based compensation to consultants and investor relations, Shares	10,000
Restricted shares issued as stock- based compensation to consultants and investor relations, Amount	$ 10	63,190			63,200
Foreign currency translation adjustment				(19,333)	(19,333)
Net loss			(1,581,217)		(1,581,217)
Ending Balance, Shares at Sep. 30, 2020	22,893,705
Ending Balance, Amount at Sep. 30, 2020	$ 22,894	$ 31,838,383	$ (20,267,348)	$ (351,502)	$ 11,242,427